Samie Modak, Sohini Das

Stories by Samie Modak, Sohini Das

Honda 2W share rises after on-board norms compliance

Honda 2W share rises after on-board norms compliance

Rediff.com   17 Jul 2024

The battle for the top spot in the two-wheeler market is intensifying. The gap between Hero MotoCorp and Honda Motorcycle & Scooter India (HMSI) in retail sales narrowed to just 45,607 units in June. This improvement comes as HMSI has clawed back market share after dipping to a historic low of 18 per cent in May 2023. Now, the retail market shares of the two companies are 28.86 per cent and 25.54 per cent, respectively, compared to 35.54 per cent and 18.05 per cent in May 2023.

Diabetes Drug Linked To Vision Loss?

Diabetes Drug Linked To Vision Loss?

Rediff.com   16 Jul 2024

Study suggested that constant use of Semaglutide may be linked to development of a condition called non-arteritic ischemic optic neuropathy.

Rs 2,000 Crore Raised Daily Jan-Jun 2024!

Rs 2,000 Crore Raised Daily Jan-Jun 2024!

Rediff.com   12 Jul 2024

Equity supply may hit Rs 6 trillion soon.

Nifty may sport new look after Sebi's F&O tweak, expand to over 200 firms

Nifty may sport new look after Sebi's F&O tweak, expand to over 200 firms

Rediff.com   6 Jul 2024

The Nifty 50 index is poised for a revamp as the revised futures and options (F&O) stock selection criteria is seen paving the way for newly listed companies to join the benchmark index, which is tracked by passive funds with combined assets under management of more than ~3.5 trillion ($44 billion). For the first time in six years, the market regulator Securities and Exchange Board of India (Sebi) has tweaked the stock selection process for the derivatives segment that clocks a turnover of ~400 trillion daily.

Promoters Sold Rs 87,000 Crore Of Shares

Promoters Sold Rs 87,000 Crore Of Shares

Rediff.com   2 Jul 2024

Prominent exits by promoters included a Rs 15,300 crore share sale in Indus Tower by Vodafone Plc, a Rs 9,300 crore share sale by the Tata group in Tata Consultancy Services.

How Kalki's Bujji Was Born

How Kalki's Bujji Was Born

Rediff.com   1 Jul 2024

'Fun stuff does, indeed, happen on X.'

'Indian rupee best-performing Asian currency this year'

'Indian rupee best-performing Asian currency this year'

Rediff.com   29 Jun 2024

'India represents one of the top opportunities with robust growth, solid fundamentals, and openness to foreign investment.'

Unlisted Shares Market Is Buzzing

Unlisted Shares Market Is Buzzing

Rediff.com   29 Jun 2024

The dealers operating in the space have jumped nearly three times over the past two years.

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com   28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Rediff.com   25 Jun 2024

After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology (biotech) company clarified that in the "rush" to develop vaccines and file appropriate patents, BBIL had missed adding ICMR's name in the original filings.

'I Hope We Don't Get A Bubble Too Soon'

'I Hope We Don't Get A Bubble Too Soon'

Rediff.com   21 Jun 2024

'China is struggling to get out of its property bubble.' 'Japan took 35 years to walk out of its equity bubble.' 'Bubbles can be difficult to forecast.'

Cleaner Fuels Driving One-Fifth Of PVs Sold In India

Cleaner Fuels Driving One-Fifth Of PVs Sold In India

Rediff.com   18 Jun 2024

Auto manufacturers have focused on launching CNG variants of their popular models to meet consumer demand for vehicles with lower running costs.

'Second-gen promoters more open to selling out'

'Second-gen promoters more open to selling out'

Rediff.com   6 Jun 2024

'There is not any negative connotation associated with it.'

Voting advisory firms divided over FMCG major ITC's hotel demerger move

Voting advisory firms divided over FMCG major ITC's hotel demerger move

Rediff.com   4 Jun 2024

Three leading domestic voting advisory firms are not on the same page over the proposed demerger and separate listing of ITC's hotel business, ITC Hotels. Institutional Investor Advisory Services (IiAS) has recommended a vote "against" the resolution, while InGovern and Stakeholders Empowerment Services (SES) have advised their clients to vote in favour. Voting on the resolution is currently underway.

'Depending on the product, the pricing pressure will always be there'

'Depending on the product, the pricing pressure will always be there'

Rediff.com   3 Jun 2024

'That is a significant milestone for us and something we aspired for.'

'Market Assumes Modi's Easy Re-Election'

'Market Assumes Modi's Easy Re-Election'

Rediff.com   29 May 2024

'We emphasise the importance of not basing investment decisions solely on electoral outcomes.' 'Instead, focusing on investing in high-quality businesses capable of prospering regardless of the political landscape is paramount.'

New-Gen COVID Jabs Coming Soon...

New-Gen COVID Jabs Coming Soon...

Rediff.com   28 May 2024

India currently does not have any XBB 1.5 variant-based vaccines available.

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Rediff.com   23 May 2024

Several firms are stepping up to help their workforce cope with soaring temperatures

Bluechips Drive Markets To $5 Trillion

Bluechips Drive Markets To $5 Trillion

Rediff.com   23 May 2024

The top 100 companies have accounted for 63% of the gains (Rs 51 trillion out of Rs 81 trillion), while firms beyond the top 100 have contributed 37 per cent (Rs 30 trillion).

Should Govt Continue Covid Vax Drive?

Should Govt Continue Covid Vax Drive?

Rediff.com   20 May 2024

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities.